Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 9:59 p.m.

    📋 AERIE PHARMACEUTICALS INC (AERI) - Clinical Trial Update

    Filing Date: 2022-05-24

    Accepted: 2022-05-24 07:30:33

    Event Type: Clinical Trial Update

    Event Details:

    Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI) Announces Clinical Trial Update Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: treatment, studies
    • Clinical Stage: Phase 3, clinical study
    • Collaboration: Dry Eye
      • expected in the second half of 2023

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC))
    • CIK: 0001337553
    • Ticker Symbol: AERI
    • Period End Date: 2022-05-24
    • Document Type: 8-K

Search

News categories